Basilea Pharmaceutica (BPMUF) Short Interest Ratio & Short Volume

Short interest is the volume of Basilea Pharmaceutica shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 224,100 shares of BPMUF short. Learn More on Basilea Pharmaceutica's current short interest.

Basilea Pharmaceutica saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 224,100 shares, an increase of 0.6% from the previous total of 222,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Basilea Pharmaceutica: Astria Therapeutics, Inc. (11.37%), Phathom Pharmaceuticals, Inc. (39.95%), Stoke Therapeutics, Inc. (15.01%), Altimmune, Inc. (25.01%), AnaptysBio, Inc. (18.16%), COMPASS Pathways plc (5.05%), Korro Bio, Inc. (2.31%), Calliditas Therapeutics AB (publ) (0.01%), Phibro Animal Health Co. (3.49%), Olema Pharmaceuticals, Inc. (14.48%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling BPMUF is an investing strategy that aims to generate trading profit from Basilea Pharmaceutica as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Basilea Pharmaceutica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPMUF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPMUF, twice per month. The most recent reporting period available is March, 31 2024.